Derma Sciences, Inc. (DSCI) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 19 PAGES: 55

More Info
									           Derma Sciences, Inc. (DSCI) - Financial and Strategic SWOT Analysis
                                          Review
        Reference Code: GDME88FSA                                                                                                Publication Date: APR 2013

          214 Carnegie Center, Suite 300                     Phone              +1 609 5144744                      Revenue         72.7 (million USD)
          Princeton, NJ                                      Fax                +1 302 6554620                      Net Profit      -12.07 (million USD)
          08540                                              Website            www.dermasciences.com               Employees       212
          United States                                      Exchange           DSCI [NASDAQ]                       Industry        Medical Equipment

       Company Overview
       Derma Sciences, Inc. (Derma Sciences) is a medical technology company, which focuses on wound care. It is a fully integrated
       manufacturer, supplier and marketer of wound care and skin care products. Its product portfolio consists of novel patented
       dressings, barrier dressings, proprietary antimicrobial dressing, proprietary line of dressings, patented advanced dressing system,
       on-adherent impregnated dressings, gauze sponges and bandages, retention devices, paste bandages and other compression
       devices.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Derma Sciences, Inc., SWOT Analysis
         Stephen T. Wills                    Director                                 Strengths                                Weaknesses
         James T. O Brien                    Director
                                                                                      Strong Liquidity Position                Over-dependence on the US
         C. Richard Stafford                 Director                                                                          Market
                                                                                      Strong Manufacturing
         Bruce F. Wesson                     Director
                                                                                      Capabilities                             Weak Bottom Line
         Brett D. Hewlett                    Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                            Threats

       Share Data                                                                     Promising Pipeline Products              Rapid Technological Changes
         Derma Sciences, Inc.
                                                                                      Aging Population                         Competitive Landscape
        Share Price (USD) as on 22-Apr-                                11.66
        2013
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        EPS (USD)                                                       -0.97        GlobalData
        Market Cap (million USD)                                         194
        Enterprise Value (million USD)                                   148
        Shares Outstanding (million)                                       17
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Apr 01, 2013         Derma Sciences Reports Revenue Of $72.6m
                                                                                                           In 2012
                                                                                      Nov 12, 2012         Derma Sciences Reports Revenue Of $19.6m
                                                                                                           In Q3 2012
                                                                                      Aug 13, 2012         Derma Sciences Reports Revenue Of $17.6m
                                                                                                           In Q2 2012
                                                                                      May 15, 2012         Derma Sciences Reports Net Sales Of $15.3m
                                                                                                           In Q1 2012
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Derma Sciences, Inc. (DSCI) - Financial and Strategic SWOT                                                                          Reference Code: GDME88FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Derma Sciences, Inc. - Key Facts ...................................................................................................................................................... 5
       Derma Sciences, Inc. - Key Employees ............................................................................................................................................. 6
       Derma Sciences, Inc. - Major Products and Services ........................................................................................................................ 7
       Derma Sciences, Inc. - Medical Equipment Pipeline Products Data .................................................................................................. 8
          Derma Sciences, Inc. Pipeline Products by Equipment Type ......................................................................................................... 8
          Derma Sciences, Inc. Pipeline Products by Development Stage .................................................................................................. 10
       Derma Sciences, Inc. - Pharmaceutical Pipeline Products Data ...................................................................................................... 12
          Derma Sciences, Inc., Pipeline Products by Therapy Area........................................................................................................... 12
          Derma Sciences, Inc., Pipeline Products by Development Phase ................................................................................................ 13
       Derma Sciences, Inc. - History ......................................................................................................................................................... 22
       Derma Sciences, Inc. - Company Statement.................................................................................................................................... 26
       Derma Sciences, Inc. - Locations And Subsidiaries ......................................................................................................................... 27
          Head Office ................................................................................................................................................................................... 27
          Other Locations & Subsidiaries ..................................................................................................................................................... 27
       Derma Sciences, Inc. - Key Manufacturing Facilities ....................................................................................................................... 28
       Section 2 – Company Analysis ......................................................................................................................................................... 29
       Derma Sciences, Inc. - Business Description ................................................................................................................................... 29
       Derma Sciences, Inc. - Corporate Strategy ...................................................................................................................................... 30
       Derma Sciences, Inc. - SWOT Analysis ........................................................................................................................................... 31
          SWOT Analysis - Overview........................................................................................................................................................... 31
          Derma Sciences, Inc. - Strengths ................................................................................................................................................. 31
             Strength - Strong Liquidity Position ........................................................................................................................................... 31
             Strength - Strong Manufacturing Capabilities ............................................................................................................................ 31
             Strength - Broad Product Portfolio ............................................................................................................................................ 31
          Derma Sciences, Inc. - Weaknesses ............................................................................................................................................ 32
             Weakness - Over-dependence on the US Market ..................................................................................................................... 32
             Weakness - Weak Bottom Line ................................................................................................................................................. 32
          Derma Sciences, Inc. - Opportunities ........................................................................................................................................... 32
             Opportunity - Promising Pipeline Products ................................................................................................................................ 32
             Opportunity - Aging Population ................................................................................................................................................. 32
             Opportunity - Strategic Initiatives .............................................................................................................................................. 33
             Opportunity - Global Wound Care Management Market ........................................................................................................... 33
          Derma Sciences, Inc. - Threats .................................................................................................................................................... 33
             Threat - Rapid Technological Changes ..................................................................................................................................... 33
             Threat - Competitive Landscape ............................................................................................................................................... 33
             Threat - Stringent Government Regulations .............................................................................................................................. 33
       Derma Sciences, Inc. - Key Competitors .......................................................................................................................................... 35
       Section 3 – Company Financial Ratios ............................................................................................................................................. 36
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 36
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 36
       Performance Chart ........................................................................................................................................................................... 38


Derma Sciences, Inc. (DSCI) - Financial and Strategic SWOT                                                                                                          Reference Code: GDME88FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Financial Performance...................................................................................................................................................................... 38
       Financial Ratios - Interim Ratios.............................................................................................................................
								
To top